Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA approves first medical device for epilepsy

July 17, 1997

Acetylcholine receptor modulators reported by SIBIA Neurosciences

July 17, 1997

Biomedica Foscama discloses adenosine antagonists for depression

July 17, 1997

Merck Sharp & Dohme reveals new tachykinin antagonists

July 17, 1997

Future therapeutic targets for AD

July 17, 1997

Long-acting benzodiazepines increase risk of car crashes in the elderly

July 16, 1997

RiboGene signs marketing agreement for intranasal metoclopramide

July 16, 1997

New antipsychotic agent goes head-to-head with established therapies

July 16, 1997

A new target for antiepileptic drugs

July 16, 1997

SB-242084: a potent and selective 5-HT2C receptor antagonist

July 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...